Maseqhala P. Nkondo-Ndaba, P. Joubert, Theona Ballyram, C. J. van Rensburg
{"title":"第一代和第二代抗精神病药物对男性精神病患者人体测量参数的影响","authors":"Maseqhala P. Nkondo-Ndaba, P. Joubert, Theona Ballyram, C. J. van Rensburg","doi":"10.4102/sajpsychiatry.v28i0.1772","DOIUrl":null,"url":null,"abstract":"Background The use of antipsychotic medication, particularly second generation antipsychotics (SGAs) is a major risk factor for cardiovascular disease in people with severe mental illness (SMI). Few studies have compared body measures of people with SMI taking first generation antipsychotics (FGAs) to those taking SGAs. Aim We compare body measures between long-term male inpatients using either FGAs or SGAs. Setting The study was conducted at Weskoppies Psychiatric Hospital, in Pretoria, Gauteng. Methods A total of 30 patients were selected from a list of male inpatients and were included in our study. Each participant had the following anthropometric measures done and these were compared between the two groups: Waist circumference (WC), body mass index (BMI), waist to hip ratio (WHR), waist to height ratio (WHtR) and hip circumference (HC). Hospital records were used to record demographic variables, diagnosis, comorbid disease and psychotropic medication for each participant. Results Participants in the FGA and SGA groups had similar body measures, resulting in similar BMI, WHR and WHtR. Participants had a mean HC of 100.5 cm, 95% confidence interval (CI) (97.68, 103.22). BMI ranged from 21.87 kg/m² to 37.65 kg/m², with an overall mean of 28.5 kg/m², 95% CI (26.69, 30.22). Participants had a mean WHtR of 0.59, 95% CI (0.56, 0.61). Participants had a mean WC of 100.6 cm and 95% CI (96.26, 104.87), and the mean WHR of both groups was 1.0. Conclusion Participants using FGAs and SGAs had similar body measures, and these indicated that this sample of male inpatients with SMI is at high risk for CVD.","PeriodicalId":51156,"journal":{"name":"South African Journal of Psychiatry","volume":"55 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2022-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Influence of first- and second-generation antipsychotics on anthropometric parameters of male psychiatric patients\",\"authors\":\"Maseqhala P. Nkondo-Ndaba, P. Joubert, Theona Ballyram, C. J. van Rensburg\",\"doi\":\"10.4102/sajpsychiatry.v28i0.1772\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background The use of antipsychotic medication, particularly second generation antipsychotics (SGAs) is a major risk factor for cardiovascular disease in people with severe mental illness (SMI). Few studies have compared body measures of people with SMI taking first generation antipsychotics (FGAs) to those taking SGAs. Aim We compare body measures between long-term male inpatients using either FGAs or SGAs. Setting The study was conducted at Weskoppies Psychiatric Hospital, in Pretoria, Gauteng. Methods A total of 30 patients were selected from a list of male inpatients and were included in our study. Each participant had the following anthropometric measures done and these were compared between the two groups: Waist circumference (WC), body mass index (BMI), waist to hip ratio (WHR), waist to height ratio (WHtR) and hip circumference (HC). Hospital records were used to record demographic variables, diagnosis, comorbid disease and psychotropic medication for each participant. Results Participants in the FGA and SGA groups had similar body measures, resulting in similar BMI, WHR and WHtR. Participants had a mean HC of 100.5 cm, 95% confidence interval (CI) (97.68, 103.22). BMI ranged from 21.87 kg/m² to 37.65 kg/m², with an overall mean of 28.5 kg/m², 95% CI (26.69, 30.22). Participants had a mean WHtR of 0.59, 95% CI (0.56, 0.61). Participants had a mean WC of 100.6 cm and 95% CI (96.26, 104.87), and the mean WHR of both groups was 1.0. Conclusion Participants using FGAs and SGAs had similar body measures, and these indicated that this sample of male inpatients with SMI is at high risk for CVD.\",\"PeriodicalId\":51156,\"journal\":{\"name\":\"South African Journal of Psychiatry\",\"volume\":\"55 1\",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2022-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South African Journal of Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4102/sajpsychiatry.v28i0.1772\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4102/sajpsychiatry.v28i0.1772","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
使用抗精神病药物,特别是第二代抗精神病药物(SGAs)是严重精神疾病(SMI)患者心血管疾病的主要危险因素。很少有研究比较服用第一代抗精神病药物(FGAs)和服用SGAs的重度精神障碍患者的身体测量。目的比较长期男性住院患者使用FGAs和SGAs的身体测量。该研究在豪登省比勒陀利亚的Weskoppies精神病院进行。方法从男性住院患者名单中选取30例患者作为研究对象。每个参与者都做了以下人体测量,并在两组之间进行比较:腰围(WC)、体重指数(BMI)、腰臀比(WHR)、腰高比(WHtR)和臀围(HC)。医院记录用于记录每位参与者的人口学变量、诊断、合并症和精神药物。结果FGA组和SGA组参与者的身体测量相似,导致BMI、WHR和WHtR相似。参与者的平均HC为100.5 cm, 95%可信区间(CI)(97.68, 103.22)。BMI范围为21.87 kg/m²至37.65 kg/m²,总体平均值为28.5 kg/m²,95% CI(26.69, 30.22)。参与者的平均WHtR为0.59,95% CI(0.56, 0.61)。参与者的平均腰围为100.6 cm, 95% CI(96.26, 104.87),两组的平均腰宽比为1.0。结论使用FGAs和SGAs的参与者有相似的身体测量,这些表明该样本的男性重度精神障碍住院患者患心血管疾病的风险很高。
Influence of first- and second-generation antipsychotics on anthropometric parameters of male psychiatric patients
Background The use of antipsychotic medication, particularly second generation antipsychotics (SGAs) is a major risk factor for cardiovascular disease in people with severe mental illness (SMI). Few studies have compared body measures of people with SMI taking first generation antipsychotics (FGAs) to those taking SGAs. Aim We compare body measures between long-term male inpatients using either FGAs or SGAs. Setting The study was conducted at Weskoppies Psychiatric Hospital, in Pretoria, Gauteng. Methods A total of 30 patients were selected from a list of male inpatients and were included in our study. Each participant had the following anthropometric measures done and these were compared between the two groups: Waist circumference (WC), body mass index (BMI), waist to hip ratio (WHR), waist to height ratio (WHtR) and hip circumference (HC). Hospital records were used to record demographic variables, diagnosis, comorbid disease and psychotropic medication for each participant. Results Participants in the FGA and SGA groups had similar body measures, resulting in similar BMI, WHR and WHtR. Participants had a mean HC of 100.5 cm, 95% confidence interval (CI) (97.68, 103.22). BMI ranged from 21.87 kg/m² to 37.65 kg/m², with an overall mean of 28.5 kg/m², 95% CI (26.69, 30.22). Participants had a mean WHtR of 0.59, 95% CI (0.56, 0.61). Participants had a mean WC of 100.6 cm and 95% CI (96.26, 104.87), and the mean WHR of both groups was 1.0. Conclusion Participants using FGAs and SGAs had similar body measures, and these indicated that this sample of male inpatients with SMI is at high risk for CVD.
期刊介绍:
The journal is the leading psychiatric journal of Africa. It provides open-access scholarly reading for psychiatrists, clinical psychologists and all with an interest in mental health. It carries empirical and conceptual research articles, reviews, editorials, and scientific letters related to psychiatry. It publishes work from various places in the world, and makes special provision for the interests of Africa. It seeks to serve its readership and researchers with the most topical content in psychiatry for clinical practice and academic pursuits, including work in the subspecialty areas of psychiatry.